Epstein Secrets

iology, mathematics, physics and computer science. The program consists of a team of visiting professors, research fellows and Ph-D students led by Martin Nowak, Professor of Mathematics and Biology at Harvard University. The fundamental laws of nature are written in the language of mathematics. Our goal i

research fellows and Ph-D students led by Martin Nowak, Professor of Mathematics and Biology at Harvard

relife to life. 3. The first quantitative model for the accumulation of driver and passenger mutations in cancer progression (in collaboration with Bert Vogelstein). 4. The fundamental laws that determine how population structure affect evolutionary dynamics. 5. A new theory for the emergence of advanced soci

From: Martin Nowak To: Jeffrey Epstein <[email protected]> Subject: Fwd: some info and papers Date: Sat, 07 Aug 2010 13:16:17 +0000 Attachments: Science06.pdf; N

From: Martin Nowak To: Jeffrey Epstein <[email protected]> Subj

I am also working on evolutionary processes in medicine such as the dynamics of virus infections and cancer. I have an excellent collaboration with Bert Vogelstein, who is one of the leading cancer biologists in the world. Many years ago my calculations helped to obtain a quantitative understanding of HIV infe

nks for the opportunity. > Best, > > > <Martin Nowak summary.docx> EFTA00412057

on this one. > Revisiting that day's conversations and Martin's work, in particular, was a pleasure. Thanks for the opportunity. > Best, > > > <Martin Nowak summary.docx> EFTA00412057

nce itself. This piece focuses on his work on eusociality in ants and prelife. (I could easily write a short follow-up piece on his cancer work with Bert Vogelstein, particularly once their forthcoming paper is published in Nature.) > All this to say that I'm not married to this format. What I've written is lon

ys on the move but nowhere has it been more in flux than at Harvard University. Indeed ten years ago, an Austrian biologist and mathematician called Martin Nowak, at the Advanced Institute for Studies at Princeton, met with an unknown New York financier called Jeffrey Epstein, to discuss the evolution of lan

what emerged was far more pragmatic than the first evolutionary theory of irregular verbs. What emerged was an entire department at Harvard, under Nowak's direction, to study the evolution of human diseases with the primary use of mathematics. The department, called the Program for Evolutionary Dynam

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

ering the big questions, a possible but perhaps ultimately insatiable desire. Much has been written about the Program for Evolutionary Dynamics and Martin Nowak's work. Nowak is also the honored recipient of numerous awards, he is a frequent guest lecturer and the author of several books. And while Jeffrey Ep

eria and viruses such as HIV. It all began in March of 2000 when Epstein, a New York fund manager with a passion for cutting- edge science, invited Nowak to organize a conference on the evolution of language. Nowak was then head of the Program in Theoretical Biology at the Institute for Advanced Study

lar and cellular behavior with the precision of an engineer and share those findings with physicians." In that same year 2010, the PED presented to Bert Vogelstein, professor and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins Kimmel Cancer Center and the Howard Hughes M

From: Lesley Groff Sent: Thursday, May 31, 2012 1:36 PM To: Jeffrey Epstein CC Subject: Fwd: 1st write-up Attachments: Martin Nowak summary.docx; Untitled attachment 00129.htm Begin forwarded message: From: Lindsay Borthwick Date: May 31, 2012 9:33:58 AM EDT To: Lesley Groff

Subject: Fwd: 1st write-up Attachments: Martin Nowak summary.docx; Untitled attachment 00129.htm Begi

nce itself. This piece focuses on his work on =usociality in ants and prelife. (I could easily write a short follow-up =iece on his cancer work with Bert Vogelstein, particularly once their =orthcoming paper is published in Nature.) All this to say that ='m not married to this format. What I've written is long a

From: Lesley Groff Sent: Sunday, June 10, 2012 12:31 PM To: Epstein Jeffrey Subject: Fwd: 1st write-up-Lindsay Borthwick Attachments: Martin Nowak summary.docx; Untitled attachment 00484.htm Sent from my iPhone ar>Begin forwarded message: From:=/b> Lindsay Borthwic Date: May 31, 2012 9:33:58

write-up-Lindsay Borthwick Attachments: Martin Nowak summary.docx; Untitled attachment 00484.htm Sent

nce itself. This piece focuses o= his work on eusociality in ants and prelife. (I could easily write a short=follow-up piece on his cancer work with Bert Vogelstein, particularly once t=eir forthcoming paper is published in Nature.) <=pan>AII this to say that I'm not married to this format. What I've written i=

York financier and science philanthropist, funded the PED's huge strides in detailing cancer resistance to inhibitor drugs. Under the direction of Martin Nowak. a Biology and Mathematics Professor at Harvard, the PED designed mathematical models showing exactly how a minority of mutated cancer cells are eit

a mathematical model from the tumorous tissue of 28 colon cancer patients at Johns I Iopkins about to embark on a course of paninunumab treatment. Nowak's findings were extraordinary: they showed that even before treatment began. less than .0001% of cells carried resistance to the inhibitor but could

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi

York financier and science philanthropist, funded the PED's huge strides in detailing cancer resistance to inhibitor drugs. Under the direction of Martin Nowak. a Biology and Mathematics Professor at Harvard, the PED designed mathematical models showing exactly how a minority of mutated cancer cells are eit

a mathematical model from the tumorous tissue of 28 colon cancer patients at Johns I Iopkins about to embark on a course of paninunumab treatment. Nowak's findings were extraordinary: they showed that even before treatment began. less than .0001% of cells carried resistance to the inhibitor but could

ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi

and science philanthropist, Jeffrey Epstein funded the PED's huge strides in detailing cancer resistance to inhibitor drugs. Under the direction of Martin Nowak, a Biology and Mathematics Professor at Harvard, the PED designed mathematical models showing exactly how a minority of mutated cancer cells are eit

at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help, EFTA00583237 Vogelstein and the PED designed a mathematical model from the tumorous tissue of 28 colon cancer patients at Johns Hopkins a

FR TK inhibitors became resistant from a single mutation of the protein T790M within the EGFR kinase domain. PED's work caught the attention of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University